2022-07-18T00:00:00.000+10:00
Ongoing
Accent
Accent
Pancreatic cancer
A Phase 1b/2a, Multicentre, Open Label Study of the Pharmacokinetics, Safety and Efficacy of AMP945 in Combination with Nab-paclitaxel and Gemcitabine in Pancreatic Cancer Patients (AMP945-PC-201)
A Phase 1b/2a, Multicentre, Open Label Study of the Pharmacokinetics, Safety and Efficacy of AMP945 in Combination with Nab-paclitaxel and Gemcitabine in Pancreatic Cancer Patients (AMP945-PC-201)
Trial overview
Clinical Area
Medical Oncology
Disease / Condition
Pancreatic cancer
Study Phase
I/IIa |
Trial Identifiers
Registration number: NCT05355298 https://clinicaltrials.gov/study/NCT05355298
|
GeneisCare Location(s)
GenesisCare North Shore
GenesisCare North Shore
:::
Principal Investigator(s)
Prof Nick Pavlakis
|